Lanean...
Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
Objective: To investigate the reversal effect of tuberostemonine on MDR in myelogenous leukemia cells K562/ADR. Methods: Human myelogenous leukemia cells K562 and their adriamycin-resistance cells K562/ADR were used. The growth curve of cells treated by tuberostemonine and the Non-toxic concentratio...
Gorde:
| Argitaratua izan da: | J Cancer |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Ivyspring International Publisher
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5436265/ https://ncbi.nlm.nih.gov/pubmed/28529625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17688 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|